Filter
789
Filtered Results: 789
Text search:
Multi-drugresistant
Tuberculosis/MDR-TB
Featured
Recommendations
95
New Publications
237
Language
Document type
No document type
604
Studies & Reports
67
Guidelines
63
Manuals
21
Strategic & Response Plan
13
Training Material
9
Fact sheets
7
Situation Updates
5
Countries / Regions
Western and Central Europe
50
Eastern Europe
37
India
33
South Africa
29
Kenya
26
Malawi
16
Nepal
15
Tanzania
15
Myanmar / Burma
15
Zambia
14
Namibia
13
Ethiopia
12
Bangladesh
12
Ukraine
12
Liberia
10
Cambodia
10
Asia
10
Rwanda
9
Global
9
Nigeria
8
Uganda
8
Ghana
7
Botswana
7
Lesotho
7
South–East Asia Region
7
Latin America and the Carribbean
7
Russia
7
Sierra Leone
5
Mozambique
5
Philippines
4
Germany
4
Indonesia
4
Peru
4
Colombia
4
Senegal
3
Zimbabwe
3
Pakistan
3
Tajikistan
3
Guinea
2
Congo, Democratic Republic of
2
Cameroon
2
Benin
2
Argentina
2
Eswatini/ Swaziland
2
El Salvador
2
Western Pacific Region
2
Armenia
2
Vietnam
2
Burkina Faso
1
South Sudan
1
Jordan
1
Afghanistan
1
Gambia
1
Papua New Guinea
1
Central African Republic
1
Switzerland
1
Madagascar
1
Sri Lanka
1
East and Southern Africa
1
West and Central Africa
1
Middle East and North Africa
1
Eastern Europe and Central Asia
1
Paraguay
1
Africa
1
Bhutan
1
Albania
1
Timor Leste/ East Timor
1
Estonia
1
Romania
1
Moldova
1
Georgia
1
Turkmenistan
1
Maldives
1
Authors & Publishers
Publication Years
Category
Countries
284
Clinical Guidelines
77
Public Health
23
Capacity Building
11
Women & Child Health
8
Key Resources
7
Pharmacy & Technologies
5
Toolboxes
TB
417
HIV
66
AMR
48
Polio
15
Refugee
14
Pharmacy
10
Ebola
8
Global Health Education
8
Caregiver
6
Rapid Response
5
NTDs
5
Health Financing Toolbox
5
Conflict
3
COVID-19
3
Disability
2
Natural Hazards
2
Mental Health
2
NCDs
2
Planetary Health
1
Meeting Report 27-29 October 2020
The overall goal of the meeting was to discuss recent changes in treatment regimens and diagnostics for drug-resistant ... and to determine how these impact on the definition of XDR-TB, with a view to revising this definition. The pre-existing definition of XDR-TB was formulated in 2006 at a meeting of the Global Taskforce on XDR-TB, convened by WHO, and has been in use for clinical and surveillance purposes, since this time.
This report presents an overview of the transition process in Azerbaijan, some sustainability aspects and challenges stemming from donor withdrawal from TB-related activities, along with recommendations on how to overcome transition-related difficu...
2nd edition.
T The Compendium has been developed as a clear and concise instrument to facilitate the understanding and planning of delivery of high-quality care for everybody affected by TB. It incorporates all recent policy guidance from WHO; foll...
his Framework begins with a desired future scenario and considers actions and interventions necessary to get there. It advocates for holistic view to address tuberculosis. The Framework revisits challenges and actions in four layers: ... specific; challenges in health systems that influence TB care; challenges in sectors beyond health that determine TB; and overarching governance issues. Multisectoral action and accountability are embedded in the Framework. The Framework is based on the principles of people-centered care and system development.
About one fourth of the world’s population is estimated to have been infected with the tuberculosis (TB) bacilli, and about 5–10% of those infected develop ... disease in their lifetime. The risk for TB disease after infection depends on several factors, the most important being the person’s immunological status. TB preventive treatment (TPT) given to people at highest risk of progressing from TB infection to disease remains a critical element to achieve the global targets of the End TB Strategy, as reiterated by the second UN High Level Meeting on TB in 2023. Delivering TPT effectively and safely necessitates a programmatic approach to implement a comprehensive package of interventions along a cascade of care: identifying individuals at highest risk, screening for TB and ruling out TB disease, testing for TB infection, and choosing the preventive treatment option that is best suited to an individual, managing adverse events, supporting medication adherence and monitoring programmatic performance.
The WHO Global tuberculosis report 2024 provides a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease, at global, regio...
Este documento presenta modelos de algoritmos que permiten investigar por métodos bacteriológicos a los pacientes para el diagnóstico de tuberculosis (TB), ... asociada al Virus de Inmunodeficiencia Humana (TB-HIV) y TB drogorresistente (TBDR).
The guidelines acknowledge that overcrowding, unhygienic conditions and high inmate turn over contribute to the spread of infectious diseases within correctional facilities. The document states that voluntary HIV counselling and testing must be offered to all inmates when they enter facilities, duri...
This handbook builds on lessons learned from surveys implemented 2015-2017 and advice provided by the Global task force on TB patient cost surveys. It provides a standardized methodology for conducting health facility-based cross-sectional surveys t...
Rev Mex Patol Clin Med Lab 2020; 67 (2): 93-112: La tuberculosis (TB) es en la actualidad la patología de tipo infeccioso que causa mayor número de muertes alrededor del mundo cada año. La percep...
The Compendium of data and evidence-related tools for use in TB planning and programming was developed as a companion document to the People-centred framework for tuberculosis programme p...
The guide is suitable and can be used for the following audiences:
1. nurses and other trained healthcare workers who can use this manual as a self-study tool and then incorporate its guidance into their practice;
2. governmental and non-governmental employers of lay and professional ... treatment adherence workers, who can provide training and guidance to their staff using the guidance in this manual;
3. TB clinicians, programme managers, policy makers and other leaders, to make them aware of the full range of interventions required by a person on TB treatment to complete his or her treatment and thus understand the gap that often exists in the support provided to patients;
4. people who, with enhanced capacity and support, can act as peer counsellors and supporters for people affected by TB. This can include family members who, in most contexts, play an important role in offering support to people with TB.
Дане руководcтво призначене для медіцінcкіх працівників іcпользующіх аудіометрію для прийняття обоcнованних рішень, орієнтованих на пацієнта для профілактики і л...
How to make your messages on tuberculosis count
WHO/HTM/STB/2009.57
Maldives has made significant strides in the area of infectious disease prevention and control. This is exemplified by elimination of malaria from Maldives in 2015 and successes in TB control. In addition, Maldives is a front runner in infectious di...
KNCV Tuberculosis Foundation - Your Partner in the fight against TB
Accessed November 2017
Of the 50 antibiotics in the pipeline, 32 target WHO priority pathogens but the majority have only limited benefits when compared to existing antibiotics. Two of these are active against the multi-drug...
The Millennium Development Goals (MDGs) showed
that global commitment and collective action
could significantly reduce the disease burdens of
three deadly communicable diseases: HIV/AIDS,
tuberculosis (...) and malaria. The MDGs helped
focus efforts on these three deadly diseases
and leveraged disease-specific programmes and
financing, thus achieving significant progress.
Myanmar, as a country going through rapid socio-political transition and institutional development also suffers with a high burden of infectious disease. An ongoing challenge has been to effectively reach its 51 million population, most of whom battle tube..., acute respiratory infections, diarrhoea and malaria including amongst under-five children.
Limited research data on the occurrence of resistant organisms in the nation have, makes it hard to estimate the exact antimicrobial resistance (AMR) scenario. Limited peer reviewed evidence indicates significant divergence from the average resistance trends in APAC region. Nevertheless, several key steps by Government of Myanmar have been instrumental in paving the way for the country to join other nations in the South East Asia Region to speed up its plan on addressing the AMR crisis. Combating antimicrobial resistance would, however, require highest political commitment, multi-sectoral coordination, sustained investment and technical assistance.
9 June 2021
Since its launch, GLASS has expanded in scope and coverage and as of May 2021, 109 countries and territories worldwide have enrolled in GLASS. A key new component in GLASS is the inclusion of antimicrobial consumption (AMC) surveillance at the national level highlighted in this fourth G...
